SCHEMBL22191187

SCHEMBL22191187

Cn1c(=O)[nH]c2ccc(-c3cnc(NCc4ccc(F)cc4)nc3)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 2/20 0.49
▸ CDK2 P24941 1/20 0.46
▸ AKT1 P31749 1/20 0.46
▸ PGR P06401 4/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ GAA P10253 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ GFER P55789 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ GRIN1 Q05586 6/20 0.44
▸ GRIN2B Q13224 6/20 0.44
▸ ADORA2A P29274 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29437819 1.00 DYRK1A (0.49) DYRK1ACDK2AKT1PGRKDM4E
SCHEMBL22191346 0.92 DYRK1A (0.48) DYRK1AKDM4EALDH1A1GAACYP1A2
SCHEMBL22191015 0.89 PGR (0.50) DYRK1ACDK2AKT1PGRKDM4E
SCHEMBL22190998 0.83 GAA (0.47) DYRK1AKDM4EALDH1A1GAACYP1A2
SCHEMBL22191163 0.81 DYRK1A (0.47) DYRK1APGRKDM4EALDH1A1GAA
SCHEMBL21156825 0.78 DYRK1A (0.61) DYRK1ACDK2AKT1PGRKDM4E
SCHEMBL30593441 0.78 DYRK1A (0.61) DYRK1ACDK2AKT1PGRKDM4E
SCHEMBL22191084 0.77 PGR (0.55) PGRCYP1A2CYP2D6MEN1KMT2A
SCHEMBL22190880 0.75 PGR (0.56) PGRMAOB
SCHEMBL22191186 0.75 PGR (0.48) DYRK1ACDK2PGRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3906028-A1 KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE Icahn School of Medicine at Mount Sinai (US) 2021-11-10 — — EP disclosed
CN-113543783-A Kinase inhibitor compounds and compositions and methods of use 西奈山伊坎医学院 2021-10-22 — — CN disclosed
WO-2020142486-A1 KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2020-07-09 — — WO disclosed
Send feedback